Chemed (CHE) Cash from Financing Activities (2009 - 2026)

Chemed's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$108.1 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 359.21% year-over-year to -$108.1 million; the TTM figure through Mar 2026 stood at -$517.3 million (down 40.97% YoY), while the FY2025 annual figure was -$432.8 million, down 20.48% from the prior year.
• Cash from Financing Activities was -$108.1 million for Q1 2026 at Chemed, up from -$172.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of -$263000.0 in Q3 2023 to a low of -$212.5 million in Q4 2024.
• Historically, Cash from Financing Activities has averaged -$69.9 million across 5 years, with a median of -$53.4 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 99.34% in 2023, then tumbled 21365.02% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$14.4 million in 2022, then surged by 57.64% to -$6.1 million in 2023, then plunged by 3392.1% to -$212.5 million in 2024, then rose by 18.67% to -$172.8 million in 2025, then jumped by 37.46% to -$108.1 million in 2026.
• The last three Cash from Financing Activities figures came in at -$108.1 million (Q1 2026), -$172.8 million (Q4 2025), and -$189.3 million (Q3 2025), per Business Quant data.